| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 6.769 | - | 60.801 | 73.057 | 79.550 | 79.598 | 84.484 |
| Total Income - EUR | - | - | - | 6.769 | - | 61.127 | 73.057 | 79.550 | 79.598 | 84.484 |
| Total Expenses - EUR | - | - | - | 520 | - | 5.090 | 6.346 | 6.456 | 14.393 | 17.733 |
| Gross Profit/Loss - EUR | - | - | - | 6.249 | - | 56.037 | 66.712 | 73.093 | 65.204 | 66.752 |
| Net Profit/Loss - EUR | - | - | - | 6.046 | - | 54.331 | 64.562 | 70.754 | 64.528 | 64.344 |
| Employees | - | - | - | 0 | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Loredanamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | - | 2.406 | 1.609 | 868 | 950 | 1.232 |
| Current Assets | - | - | - | 6.292 | - | 52.609 | 79.177 | 70.512 | 64.824 | 64.664 |
| Inventories | - | - | - | 0 | - | 0 | 0 | 0 | 63 | 62 |
| Receivables | - | - | - | 0 | - | 1.976 | 14.976 | 50.755 | 54.673 | 47.396 |
| Cash | - | - | - | 6.292 | - | 50.633 | 64.201 | 19.756 | 10.089 | 17.206 |
| Shareholders Funds | - | - | - | 6.089 | - | 54.381 | 80.311 | 70.802 | 64.864 | 64.453 |
| Social Capital | - | - | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 203 | - | 634 | 476 | 577 | 910 | 1.443 |
| Income in Advance | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Loredanamed S.r.l.